Research Use Only: Why Labs Must Check Intended Use
Learn what research use only means for labs, why FDA evaluates intended use beyond labels, and what to verify before reusing RUO components in an LDT.
Research Peptide Safety: 3 Checks Before a Lot Enters Your Assay
Check each peptide lot’s COA, purity, and handling requirements before an assay. Learn how researchers can verify supplier claims and match peptide grade…
ACE-031 Research for Labs: 2026 Primate Gains, Safety Risks Persist
ACE-031 research combines human trial results with 2026 primate findings, explains persistent vascular risks, and outlines checks for laboratory sourcing.
PEG-MGF Research: Native Studies Do Not Test the Pegylated Form
Learn what preclinical MGF studies show, why they do not establish PEG-MGF effects, and how researchers can check peptide quality with COAs, MS, and HPLC.
Thymosin Alpha 1 Research for Labs: Check COAs Before Sourcing
Thymosin alpha 1 research finds mixed clinical evidence by indication. Trial design, COA review, and supplier checks support rigorous studies in the lab.
5 Amino 1MQ Research: What 11 Days in Mice Can Reveal
Review 5 Amino 1MQ’s NNMT mechanism, rodent evidence, pharmacokinetics, assays, study design, and supplier checks; human safety and efficacy remain unproven.
0.10–0.5% Thresholds Change How Researchers Assess Peptide Impurities
For researchers and regulators: when 0.10–0.5% peptide impurities demand immunogenicity assessment, orthogonal testing, and a complete COA.
Researchers: Peptide Stability Testing, Lab Ready ICH Protocols and MAM
Practical, ICH aligned peptide stability testing for researchers: lab ready protocols, sample‑prep tips, MAM/LC‑MS analytics, troubleshooting, and COA…
35 Preclinical, 1 Clinical: BPC-157 Research for Lab Trials
A researcher-focused synthesis of BPC-157 preclinical outcomes, VEGFR2 and Akt and eNOS mechanisms, a plasma half-life under 30 minutes, and concrete PK…
Mechanism First Mod GRF 1-29 for Researchers: Protocols & QC
Mechanism-first reference for researchers: how Mod GRF 1-29 triggers discrete GH pulses, practical 100–200 mcg dosing, monitoring endpoints, and a…